HCPConnect

For HCPsIntended for HCPs.

Specialty Drug Updates

Pulmonology Clinical Coverage

Specialty-focused drug approvals, safety updates, trial context, and clinical reference coverage for healthcare professionals.

Clinical Coverage

Search drug updates and clinical coverage.

3 loaded
Pulmonology

FDA Approves Depemokimab for Severe Asthma: Once-Yearly Injection for Eosinophilic Phenotype

Depemokimab approved for severe asthma: once-yearly injection for eosinophilic phenotype, enhancing treatment options.

4h ago|3 min read|Dr. Nikhil Chatterjee
Pulmonology

FDA Approves Depemokimab for Severe Asthma: Eosinophilic Phenotype Treatment

FDA approves depemokimab for severe asthma: new treatment for eosinophilic phenotype.

Apr 30|3 min read|Dr. Nikhil Chatterjee
Pulmonology

Severe Asthma Biologics: Mepolizumab, Benralizumab, Dupilumab, Tezepelumab, and Depemokimab Insights for 2025

Explore the latest insights on severe asthma biologics: mepolizumab, benralizumab, dupilumab, tezepelumab, and depemokimab for 2025.

Apr 29|3 min read|Dr. Nikhil Chatterjee

All current updates loaded